These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 8207986)
1. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR Leukemia; 1994 Jun; 8(6):929-33. PubMed ID: 8207986 [TBL] [Abstract][Full Text] [Related]
2. Treatment of acute promyelocytic leukemia with all-trans retinoic acid: an update of the New York experience. Warrell RP; Maslak P; Eardley A; Heller G; Miller WH; Frankel SR Leukemia; 1994; 8 Suppl 2():S33-7. PubMed ID: 7815834 [TBL] [Abstract][Full Text] [Related]
3. Morbidity and costs of remission induction therapy with all-trans retinoic acid compared with standard chemotherapy in acute promyelocytic leukemia. Eardley AM; Heller G; Warrell RP Leukemia; 1994 Jun; 8(6):934-9. PubMed ID: 8207987 [TBL] [Abstract][Full Text] [Related]
4. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience]. Rolovitsh Z; Cholovitsh M; Elezovitsh I; Vidovitsh A; Radoshevitsh-Radojkovitsh N; Boshkovitsh D; Novak A; Basara N Srp Arh Celok Lek; 1995; 123(11-12):279-85. PubMed ID: 16296239 [TBL] [Abstract][Full Text] [Related]
5. Early mortality and the retinoic acid syndrome in acute promyelocytic leukemia: impact of leukocytosis, low-dose chemotherapy, PMN/RAR-alpha isoform, and CD13 expression in patients treated with all-trans retinoic acid. Vahdat L; Maslak P; Miller WH; Eardley A; Heller G; Scheinberg DA; Warrell RP Blood; 1994 Dec; 84(11):3843-9. PubMed ID: 7949141 [TBL] [Abstract][Full Text] [Related]
6. All-trans retinoic acid for acute promyelocytic leukemia. Results of the New York Study. Frankel SR; Eardley A; Heller G; Berman E; Miller WH; Dmitrovsky E; Warrell RP Ann Intern Med; 1994 Feb; 120(4):278-86. PubMed ID: 8291820 [TBL] [Abstract][Full Text] [Related]
7. PML-RAR alpha fusion transcripts by RNA PCR in acute promyelocytic leukemia in remission and its correlation with clinical outcome. Ikeda K; Sasaki K; Tasaka T; Nagai M; Kawanishi K; Takahara J; Irino S Int J Hematol; 1994 Oct; 60(3):197-205. PubMed ID: 7858239 [TBL] [Abstract][Full Text] [Related]
8. Detection of minimal residual disease in acute promyelocytic leukemia by a reverse transcription polymerase chain reaction assay for the PML/RAR-alpha fusion mRNA. Miller WH; Levine K; DeBlasio A; Frankel SR; Dmitrovsky E; Warrell RP Blood; 1993 Sep; 82(6):1689-94. PubMed ID: 8400225 [TBL] [Abstract][Full Text] [Related]
10. Comparison of anthracycline-based combination chemotherapy with or without all-trans retinoic acid in acute promyelocytic leukemia. Raza S; Ullah K; Ahmed P; Khan B J Coll Physicians Surg Pak; 2008 Sep; 18(9):546-50. PubMed ID: 18803891 [TBL] [Abstract][Full Text] [Related]
11. In vitro all-trans retinoic acid (ATRA) sensitivity and cellular retinoic acid binding protein (CRABP) levels in relapse leukemic cells after remission induction by ATRA in acute promyelocytic leukemia. Cornic M; Delva L; Castaigne S; Lefebvre P; Balitrand N; Degos L; Chomienne C Leukemia; 1994; 8 Suppl 2():S16-9. PubMed ID: 7815831 [TBL] [Abstract][Full Text] [Related]
12. Constitutive expression of cellular retinoic acid binding protein II and lack of correlation with sensitivity to all-trans retinoic acid in acute promyelocytic leukemia cells. Zhou DC; Hallam SJ; Lee SJ; Klein RS; Wiernik PH; Tallman MS; Gallagher RE Cancer Res; 1998 Dec; 58(24):5770-6. PubMed ID: 9865735 [TBL] [Abstract][Full Text] [Related]
13. Long-term survival and prognostic study in acute promyelocytic leukemia treated with all-trans-retinoic acid, chemotherapy, and As2O3: an experience of 120 patients at a single institution. Hu J; Shen ZX; Sun GL; Chen SJ; Wang ZY; Chen Z Int J Hematol; 1999 Dec; 70(4):248-60. PubMed ID: 10643151 [TBL] [Abstract][Full Text] [Related]
14. Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival. Degos L Leukemia; 1994 Jun; 8(6):911-3. PubMed ID: 8207982 [TBL] [Abstract][Full Text] [Related]
15. Pilot study of all-trans retinoic acid as post-remission therapy in patients with acute promyelocytic leukemia. Seiter K; Miller WH; Feldman EJ; Ahmed T; Arlin Z Leukemia; 1995 Jan; 9(1):15-8. PubMed ID: 7845010 [TBL] [Abstract][Full Text] [Related]
16. Molecular monitoring of minimal residual disease in acute promyelocytic leukemia by the polymerase chain reaction assay for the PML/RAR alpha (retinoic acid receptor-alpha) fusion transcript in patients treated with all-trans retinoic acid followed by chemotherapy. Nemet D; Grahovac B; Labar B; Mrsić M; Radman I; Bogdanić V; Hitrec V; Zaher D; Aurer I; Sertić D Haematologica; 1995; 80(3):238-40. PubMed ID: 7672716 [TBL] [Abstract][Full Text] [Related]
17. Therapy of acute promyelocytic leukemia: all-trans retinoic acid and beyond. Tallman MS Leukemia; 1998 Sep; 12 Suppl 1():S37-40. PubMed ID: 9777894 [TBL] [Abstract][Full Text] [Related]
18. Is acute promyelocytic leukemia a curable disease? Treatment strategy for a long-term survival. Degos L Leukemia; 1994; 8 Suppl 2():S6-8. PubMed ID: 7815840 [TBL] [Abstract][Full Text] [Related]
20. [Treatment of acute promyelocytic leukemia by all trans retinoic acid]. Castaigne S; Degos L C R Seances Soc Biol Fil; 1995; 189(4):515-20. PubMed ID: 8564565 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]